Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor Alpha
100%
Malignant Neoplasm
100%
Endocrine Therapy
50%
Cancer Epidemiology
50%
Breast Cancer
50%
Prostate Cancer
50%
Nonalcoholic Fatty Liver
50%
Exportin 1
50%
Estrogen Receptor
50%
Hormone Receptor
50%
Fatty Acid
50%
Transcriptome
50%
Fulvestrant
37%
Tumor Regression
33%
Selinexor
33%
Liver Tumor
25%
Long Term Exposure
25%
Normal Human
25%
RNA-Sequencing
25%
Serine
25%
Nude Mouse
25%
Peroxisome Proliferator Activated Receptor
25%
Cancer Recurrence
16%
Estrogen Receptor Positive Breast Cancer
16%
Hormone
16%
Estrogen Receptor Antagonist
12%
Prevalence
7%
Intestine Flora
7%
Disease
7%
Cardiovascular Disease
7%
Metabolic Disorder
7%
Prostate Tumor
7%
Flame Retardant
7%
Cosmetic
7%
Cancer Incidence
7%
Fibrosis
7%
Liver Cirrhosis
7%
Carcinogenicity
5%
Clinical Trial
5%
Keyphrases
Gut Microbial Metabolism
50%
Human Prostate
50%
Uterus
50%
Combined Targeting
50%
Window of Vulnerability
50%
Endocrine Therapy
50%
Breast Cancer Epidemiology
50%
Hepatosteatosis
50%
Endocrine Resistance
50%
Hormone Receptor-positive Breast Cancer
50%
Postmenopausal Hormones
50%
XPO1
37%
Anticancer Strategy
33%
Recurrence Risk
25%
Nutrient Therapy
25%
Tumor Regression
25%
Selinexor
25%
Estrogen Receptor-positive
25%
Fulvestrant
18%
Median Overall Survival
16%
Prostaspheres
16%
Overall Survival of Patients
16%
Diet Therapy
16%
Therapy Efficacy
12%
Liver Metastatic
12%
Estrogen Receptor-positive Metastatic Breast Cancer
12%
Prostate Cells
8%
PFOA Exposure
8%
Estrogen Signaling
8%
Cardiovascular Complications
8%
Improved Patient Outcomes
8%
Preneoplastic
8%
Therapeutic Pathways
8%
Comprehensive Intervention
8%
Metastasis Sites
6%
Fasting-mimicking Diet
6%
Extracellular Matrix Hydrogel
6%
Dietary Strategies
6%
Glucose Metabolic Enzymes
6%
Estrogen Receptor Antagonist
6%
Liver Metastasectomy
6%
Metastatic Liver Tumor
6%
Tumor Drugs
6%
Liver Tumor
6%
Glycogen Deposition
6%
Tumor Metabolism
6%
Liver Weight
5%
Weight Accumulation
5%
Collagen Deposition
5%
Liver Lipid
5%
Metabolic Pathway Analysis
5%
Liver Transcriptome
5%
Reproductive Cancer
5%
Plasma Metabolites
5%
Estrogen Receptor Ligands
5%
Glutathione Metabolism
5%
Pre-clinical and Clinical Trials
5%
Plasma Factors
5%
Blood Metabolites
5%
Biochemistry, Genetics and Molecular Biology
Postmenopause
50%
Estrogen Receptor Alpha
50%
Progenitor Cell
50%
XPO1
37%
Liver Weight
25%
Ob/Ob Mouse
25%
Premenopause
25%
Glutathione Metabolism
25%
Metabolome
7%
Metabolic Pathway
7%
Cell Fate
7%
Peroxisome Proliferator-Activated Receptor
7%
Tumor Spheroid
7%
Gene Expression Profiling
7%
Transcriptome
7%
RNA Sequence
7%
Serine
7%
Normal Human
7%
Warburg Effect
7%
Nude Mouse
7%
Cell Proliferation
7%
Stem Cell Self-Renewal
7%
Signal Transduction
7%
Metabolomics
7%
Plasma Factor
5%
